Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Iterum Therapeutics plc ITRMF

Set alert

Price alert · ITRMF

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.024 Day range 0.0249
0.00001 52-week range 0.70
YTD
-100.00%
1 year
-100.00%
Open
0.0249
Prev close
0.00001
Mkt cap
532
Vol
26.21K
Avg vol
1.38K
EPS
-7.20
P/E
0.00
More statistics
Low
0.024
High
0.0249

6M chart

Chart tools
Interval
1m5m15m30m

Signals (19)
NameDateAgo
MACD: Buy SignalAug 17, 20262 months ago
MACD: Sell SignalJul 30, 20263 months ago
RSI: OversoldJul 30, 20263 months ago
MACD: Buy SignalJul 29, 20263 months ago
SMA: BearishJul 14, 20263 months ago
MACD: Sell SignalJul 14, 20263 months ago
MACD: Buy SignalJul 13, 20263 months ago
SMA: BullishJul 10, 20263 months ago
SMA: BearishJul 8, 20263 months ago
MACD: Sell SignalJul 8, 20263 months ago
MACD: Buy SignalJun 25, 20264 months ago
SMA: BullishJun 22, 20264 months ago
SMA: BearishJun 17, 20264 months ago
SMA: BullishJun 15, 20264 months ago
SMA: BearishJun 12, 20264 months ago
MACD: Sell SignalJun 9, 20264 months ago
SMA: BullishMay 29, 20265 months ago
SMA: BearishMay 28, 20265 months ago
SMA: BullishMay 26, 20265 months ago

Financial health

Altman Z-Score

-23.97 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.4×
FY 2016: -7.2×FY 2017: -3.3×FY 2018: -0.8×FY 2019: -9.5×FY 2020: -0.5×FY 2021: -0.7×FY 2022: -0.2×FY 2023: -0.7×FY 2024: -1.4×
FY 2016 5y median -0.7× FY 2024
P/S 0.0×
FY 2016: 0.0×FY 2017: 208×FY 2018: 54.6×FY 2019: 1916×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2016 5y median 0.0× FY 2024
P/B -8.5×
FY 2016: 119×FY 2017: 2.7×FY 2018: 0.7×FY 2019: -2.7×FY 2020: -7.0×FY 2021: 1.3×FY 2022: 0.4×FY 2023: -4.0×FY 2024: -8.5×
FY 2016 5y median -4.0× FY 2024
P/FCF -1.3×
FY 2016: -238×FY 2017: -3.4×FY 2018: -0.6×FY 2019: -0.9×FY 2020: -6.5×FY 2021: -4.0×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -1.3×
FY 2016 5y median -1.3× FY 2024
EV/EBITDA -2.6×
FY 2016: 333224×FY 2017: -3.3×FY 2018: -0.2×FY 2019: -0.9×FY 2020: -10.8×FY 2021: -0.8×FY 2022: -0.5×FY 2023: -1.1×FY 2024: -2.6×
FY 2016 5y median -1.1× FY 2024
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 192×FY 2018: 18.4×FY 2019: 2346×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2016 5y median 0.0× FY 2024
FCF Yield -76.8%
FY 2016: -0.4%FY 2017: -29.7%FY 2018: -160.1%FY 2019: -115.6%FY 2020: -15.3%FY 2021: -24.8%FY 2022: -180.3%FY 2023: -154.1%FY 2024: -76.8%
FY 2016 5y median -76.8% FY 2024

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: -5798.2%FY 2018: -8810.0%FY 2019: -275732.4%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2016: 0.0%FY 2017: -5788.6%FY 2018: -8867.2%FY 2019: -278729.7%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024
ROE 607.1%
FY 2016: -59.4%FY 2017: -74.5%FY 2018: -107.6%FY 2019: 393.1%FY 2020: 102.9%FY 2021: -182.3%FY 2022: -158.7%FY 2023: 599.3%FY 2024: 607.1%
FY 2016 5y median 102.9% FY 2024
ROIC -45.1%
FY 2016: -58.9%FY 2017: -74.3%FY 2018: -88.3%FY 2019: 2101.4%FY 2020: 1741.2%FY 2021: -30.4%FY 2022: -52.3%FY 2023: -372.6%FY 2024: -45.1%
FY 2016 5y median -45.1% FY 2024
ROA -55.6%
FY 2016: -50.0%FY 2017: -62.9%FY 2018: -78.7%FY 2019: -400.5%FY 2020: -158.6%FY 2021: -100.1%FY 2022: -66.5%FY 2023: -146.1%FY 2024: -55.6%
FY 2016 5y median -100.1% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 71.1%FY 2019: -95.7%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 FY 2024
Operating Income 60.6%
FY 2016: 0.0%FY 2017: -120.5%FY 2018: -159.9%FY 2019: -33.3%FY 2020: 68.5%FY 2021: 23.6%FY 2022: -23.8%FY 2023: -56.2%FY 2024: 60.6%
FY 2016 FY 2024
EPS (diluted) 57.4%
FY 2016: 0.0%FY 2017: -118.4%FY 2018: -69.3%FY 2019: 92.8%FY 2020: -357.6%FY 2021: 74.1%FY 2022: 56.8%FY 2023: 18.5%FY 2024: 57.4%
FY 2016 FY 2024
Free Cash Flow 32.0%
FY 2016: 0.0%FY 2017: -178.1%FY 2018: -141.9%FY 2019: -7.9%FY 2020: 33.4%FY 2021: 70.8%FY 2022: -16.6%FY 2023: -112.3%FY 2024: 32.0%
FY 2016 FY 2024

Financial Health

Current Ratio 1.4×
FY 2016: 6.1×FY 2017: 6.2×FY 2018: 6.9×FY 2019: 0.3×FY 2020: 0.5×FY 2021: 6.4×FY 2022: 6.9×FY 2023: 1.9×FY 2024: 1.4×
FY 2016 5y median 1.9× FY 2024
Quick Ratio 1.4×
FY 2016: 6.1×FY 2017: 6.2×FY 2018: 7.6×FY 2019: 0.3×FY 2020: 0.5×FY 2021: 6.4×FY 2022: 6.9×FY 2023: 1.9×FY 2024: 1.4×
FY 2016 5y median 1.9× FY 2024
Debt / Equity -11.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: -0.8×FY 2020: -1.0×FY 2021: 0.6×FY 2022: 1.1×FY 2023: -3.0×FY 2024: -11.2×
FY 2016 5y median -1.0× FY 2024
Net Debt / EBITDA -1.0×
FY 2016: -3101×FY 2017: 0.3×FY 2018: 0.4×FY 2019: -0.2×FY 2020: -0.9×FY 2021: -0.0×FY 2022: -0.2×FY 2023: -0.4×FY 2024: -1.0×
FY 2016 5y median -0.4× FY 2024
Interest Coverage -7.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -180×FY 2019: -118×FY 2020: -2.1×FY 2021: -4.4×FY 2022: -12.9×FY 2023: 0.0×FY 2024: -7.4×
FY 2016 5y median -4.4× FY 2024

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2016 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31